Herbas VPB

Print
EN | LT
LT - ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES
EN - ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/63
C12N 15/10
C40B 40/08
C12N 9/22
European patent
(11) Number of the document 3011035
(13) Kind of document T
(96) European patent application number 14738672.6
Date of filing the European patent application 2014-06-10
(97) Date of publication of the European application 2016-04-27
(45) Date of publication and mention of the grant of the patent 2020-05-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/041790
Date 2014-06-10
PCT application publication
(87) Number WO 2014/204723
Date 2014-12-24
Priority applications
(30) Number Date Country code
201361836123 P 2013-06-17 US
201361915397 P 2013-12-12 US
Inventors
(72)
ZHANG, Feng, US
EBERT, Benjamin, Levine, US
HECKL, Dirk, DE
Grantee
(73) The Brigham and Women`s Hospital, Inc., 75 Francis Street, Boston, MA 02115, US
The Broad Institute, Inc., 415 Main Street, Cambridge, MA 02142, US
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, US
Title
(54) ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES
  ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES
Last update date 2021-04-30